<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Cancer Urology</journal-id><journal-title-group><journal-title xml:lang="en">Cancer Urology</journal-title><trans-title-group xml:lang="ru"><trans-title>Онкоурология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1726-9776</issn><issn publication-format="electronic">1996-1812</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1399</article-id><article-id pub-id-type="doi">10.17650/1726-9776-2021-17-2-93-102</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. URINARY BLADDER CANCER</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ДИАГНОСТИКА И ЛЕЧЕНИЕ ОПУХОЛЕЙ МОЧЕПОЛОВОЙ СИСТЕМЫ. Рак мочевого пузыря</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Comparison of clips and electrosurgical instruments in sealing of lymphatic vessels during pelvic lymph node dissection at the time of radical cystectomy</article-title><trans-title-group xml:lang="ru"><trans-title>Профилактика развития лимфатических осложнений: сравнение клипс и электрохирургических инструментов при радикальной цистэктомии c тазовой лимфодиссекцией</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3764-6131</contrib-id><name-alternatives><name xml:lang="en"><surname>Kotov</surname><given-names>S. V.</given-names></name><name xml:lang="ru"><surname>Котов</surname><given-names>С. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>1 Ostrovityanova St., Moscow 117997; 8 Leninskiy Prospekt, Moscow 119049.</p></bio><bio xml:lang="ru"><p>117997 Москва, ул. Островитянова, 1; 119049 Москва, Ленинский проспект, 8.</p></bio><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8073-2708</contrib-id><name-alternatives><name xml:lang="en"><surname>Prostomolotov</surname><given-names>A. О.</given-names></name><name xml:lang="ru"><surname>Простомолотов</surname><given-names>А. О.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Artyom O. Prostomolotov.</p><p>1 Ostrovityanova St., Moscow 117997; 8 Leninskiy Prospekt, Moscow 119049.</p></bio><bio xml:lang="ru"><p>Простомолотов Артём Олегович - аспирант кафедры урологии и андрологии лечебного факультета.</p><p>117997 Москва, ул. Островитянова, 1; 119049 Москва, Ленинский проспект, 8.</p></bio><email>artem.prostomolotov@mail.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7088-5420</contrib-id><name-alternatives><name xml:lang="en"><surname>Nemenov</surname><given-names>A. A.</given-names></name><name xml:lang="ru"><surname>Неменов</surname><given-names>А. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>1 Ostrovityanova St., Moscow 117997; 8 Leninskiy Prospekt, Moscow 119049.</p></bio><bio xml:lang="ru"><p>117997 Москва, ул. Островитянова, 1; 119049 Москва, Ленинский проспект, 8.</p></bio><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1643-0836</contrib-id><name-alternatives><name xml:lang="en"><surname>Klimenko</surname><given-names>A. A.</given-names></name><name xml:lang="ru"><surname>Клименко</surname><given-names>А. A.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>1 Ostrovityanova St., Moscow 117997; 8 Leninskiy Prospekt, Moscow 119049.</p></bio><bio xml:lang="ru"><p>117997 Москва, ул. Островитянова, 1; 119049 Москва, Ленинский проспект, 8.</p></bio><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2389-4118</contrib-id><name-alternatives><name xml:lang="en"><surname>Pavlov</surname><given-names>I. S.</given-names></name><name xml:lang="ru"><surname>Павлов</surname><given-names>И. С.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>1 Ostrovityanova St., Moscow 117997; 8 Leninskiy Prospekt, Moscow 119049.</p></bio><bio xml:lang="ru"><p>117997 Москва, ул. Островитянова, 1; 119049 Москва, Ленинский проспект, 8.</p></bio><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia</institution></aff><aff><institution xml:lang="ru">Российский национальный исследовательский медицинский университет им. Н.И. Пирогова Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">N.I. Pirogov City Clinical Hospital No. 1, Moscow Healthcare Department</institution></aff><aff><institution xml:lang="ru">Городская клиническая больница № 1 им. Н.И. Пирогова Департамента здравоохранения г. Москвы</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2021-07-25" publication-format="electronic"><day>25</day><month>07</month><year>2021</year></pub-date><volume>17</volume><issue>2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>93</fpage><lpage>102</lpage><history><date date-type="received" iso-8601-date="2021-01-23"><day>23</day><month>01</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2021-05-31"><day>31</day><month>05</month><year>2021</year></date></history><permissions><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://oncourology.abvpress.ru/oncur/article/view/1399">https://oncourology.abvpress.ru/oncur/article/view/1399</self-uri><abstract xml:lang="en"><p><bold>Background</bold>. Bladder cancer is very common and real problem in oncourology. The main treatment for muscle invasive bladder cancer is radical cystectomy (RC). RC with pelvic lymph node dissection (PLND) may be associated with an increased risk of developing lymphatic complications such as lymphedema, prolonged lymphorrhea, and the formation of lymphocele.</p><p><bold>Objective</bold>: to compare the efficiency of clips and surgical instruments for preventing the development of lymphatic complications during PLND at the time of RC.</p><p><bold>Materials and methods</bold>. From January 2016 to October 2020 at the N.I. Pirogov Russian National Research Medical University on the basis of N.I. Pirogov City Clinical Hospital No. 1 were performed 60 RC with PLND. All patients were divided into two groups. The 1<sup>st</sup> group included patients who underwent the sealing of lymphatic vessels using titanium/polymer clips (<italic>n</italic> = 30). In the 2<sup>nd</sup> group the sealing was performed using ultrasonic/bipolar instruments (<italic>n</italic> = 30). All operations were performed by one surgeon. The study used univariate and multivariate logistic regression analysis.</p><p><bold>Results</bold>. The overall percentage of lymphatic complications was 29 (48.3 %) out of 60 patients. Out of them 7 (11.7 %) patients developed symptomatic lymphocele, and 3 (5.0 %) developed asymptomatic lymphocele, prolonged lymphorrhea was observed in 17 (28.3 %) patients, lymphedema of the lower extremities or genitals in 2 (3.3 %). The percentage of lymphatic complications in the 1<sup>st</sup> group was 66.7 % (<italic>n</italic> = 20), and in the 2<sup>nd</sup> group - 30.0 % (<italic>n</italic> = 9) (<italic>p</italic> = 0.004). In multivariate analysis the statistical significance was (<italic>p</italic> = 0.014), a high odds ratio (6.83; 95 % confidence interval 1.48-31.49) was observed with sealing of lymphatic vessels with clips, while a low odds ratio (0.14; 95 % confidence interval 0.03-0.67) was found with electrosurgical instruments.</p><p><bold>Conclusion</bold>. The use of ultrasonic or bipolar electrosurgical instruments can be an effective method for preventing the development of lymphatic complications during PLND at the time of RC.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Введение</bold>. Рак мочевого пузыря является актуальной проблемой в онкоурологии. Основной метод лечения мышечноинвазивного рака мочевого пузыря - радикальная цистэктомия (РЦЭ). Выполнение РЦЭ с тазовой лимфаденэктомией (ТЛАЭ) может быть связано с повышенным риском развития лимфатических осложнений, таких как лимфедема, длительная лимфорея и формирование лимфатических кист.</p><p><bold>Цель исследования</bold> - сравнить эффективность клипс и электрохирургических инструментов в профилактике развития лимфатических осложнений при РЦЭ с ТЛАЭ.</p><p><bold>Материалы и методы</bold>. С января 2016 г. по октябрь 2020 г. включительно в университетской клинике урологии РНИМУ им. Н.И. Пирогова на базе Городской клинической больницы № 1 им. Н.И. Пирогова было выполнено 60 РЦЭ с ТЛАЭ. Все пациенты были разделены на 2 группы: 1-я (<italic>n</italic> = 30) - пациенты, которым выполняли лигирование лимфатических сосудов с помощью титановых/полимерных клипс; 2-я (<italic>n</italic> = 30) - пациенты, у которых при лигировании использовались электрохирургические инструменты. Все операции были выполнены одним хирургом. В исследовании использовали однофакторный и многофакторный анализы.</p><p><bold>Результаты</bold>. Лимфогенные осложнения зарегистрированы у 29 (48,3 %) из 60 пациентов. Из них у 7 (11,7 %) пациентов развились симптоматические лимфатические кисты, у 3 (5,0 %) - асимптоматические лимфатические кисты, длительная лимфорея присутствовала у 17 (28,3 %) пациентов, лимфедема нижних конечностей или половых органов -у 2 (3,3 %). Частота развития лимфатических осложнений в 1-й группе составила 66,7 % (<italic>n</italic> = 20), во 2-й - 30,0 % (<italic>n</italic> = 9) (<italic>p</italic> = 0,004). При многофакторном анализе статистическая значимость составила p = 0,014, высокое отношение шансов (6,83; 95 % доверительный интервал 1,48-31,49) наблюдалось при лигировании лимфатических сосудов клипсами, в то время как низкое отношение шансов (0,14; 95 % доверительный интервал 0,03-0,67) обнаружено при использовании электрохирургических инструментов.</p><p><bold>Заключение</bold>. Использование ультразвукового или биполярного электрохирургического инструмента может быть эффективным методом профилактики развития лимфатических осложнений при РЦЭ с ТЛАЭ.</p></trans-abstract><kwd-group xml:lang="en"><kwd>lymphatic cyst</kwd><kwd>lymphorrhea</kwd><kwd>radical cystectomy</kwd><kwd>pelvic lymph node dissection</kwd><kwd>clips</kwd><kwd>electrosurgical instruments</kwd><kwd>risk factor</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>лимфатическая киста</kwd><kwd>лимфорея</kwd><kwd>радикальная цистэктомия</kwd><kwd>тазовая лимфодиссекция</kwd><kwd>клипсы</kwd><kwd>электрохирургические инструменты</kwd><kwd>фактор риска</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Stein J.P., Lieskovsky G., Cote R. et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 2001;19(3):666-75. DOI: 10.1200/JCO.2001.19.3.666.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Hautmann R.E., de Petriconi R.C., Pfeiffer C., Volkmer B.G. Radical cystectomy for urothelial carcinoma of the bladder without neoadjuvant or adjuvant therapy: long-term results in 1100 patients. Eur Urol 2012;61(5):1039-47. DOI: 10.1016/j.eururo.2012.02.028.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Novotny V., Hakenberg O.W., Wiessner D. et al. Perioperative complications of radical cystectomy in a contemporary series. Eur Urol 2007;51(2):397-401. DOI: 10.1016/j.eururo.2006.06.014.</mixed-citation></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">Kotov S.V., Khachatryan A.L., Guspanov R.I. et al. Evaluation of surgical complications incidence after radical cystectomy. Onkourologiya = Cancer Urology 2018;14(4):95-102. (In Russ.). DOI: 10.17650/1726-9776-2018-14-4-95-102</mixed-citation><mixed-citation xml:lang="ru">Котов С.В., Хачатрян А.Л., Гуспанов Р.И. и др. Оценка частоты послеоперационных хирургических осложнений у пациентов, подвергшихся радикальной цистэктомии. Онкоурология 2018;14(4):95-102. DOI: 10.17650/1726-9776-2018-14-4-95-102</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><mixed-citation>Gschwend J.E., Heck M.M., Lehmann J. et al. Extended versus limited lymph node dissection in bladder cancer patients undergoing radical cystectomy: survival results from a prospective randomized trial. Eur Urol 2019;75(4):604-11. DOI: 10.1016/j.eururo.2018.09.047.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Mundhenk J., Hennenlotter J., Alloussi S. et al. Influence of body mass index, surgical approach and lymphadenectomy on the development of symptomatic lymphoceles after radical prostatectomy. Urol Int 2013;90(3):270-6. DOI: 10.1159/000347043.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Oderda M., Diamand R., Albisinni S. et al. Indications for and complications of pelvic lymph node dissection in prostate cancer: accuracy of available nomograms for the prediction of lymph node invasion. BJU Int 2021 Mar;127(3):318-25. DOI: 10.1111/bju.15220.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Thomas C., Ziewers S., Thomas A. et al. Development of symptomatic lymphoceles after radical prostatectomy and pelvic lymph node dissection is independent of surgical approach: a single-center analysis. Int Urol Nephrol 2019;51(4):633-40. DOI: 10.1007/s11255-019-02103-7.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Gotto G.T., Yunis L.H., Guillonneau B. et al. Predictors of symptomatic lymphocele after radical prostatectomy and bilateral pelvic lymph node dissection. Int J Urol 2011;18(4):291-6. DOI: 10.1111/j.1442-2042.2010.02710.x.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Sforza S., Tellini R., Grosso A.A. et al. Can we predict the development of symptomatic lymphocele following robot-assisted radical prostatectomy and lymph node dissection? Results from a tertiary referral Centre. Scand J Urol 2020;54(4):328-33. DOI: 10.1080/21681805.2020.1784270.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Thomas C., van de Plas J., Tsaur I. et al. Incidence, risk factors and management of symptomatic lymphoceles after radical retropubic prostatectomy. Urol Pract 2017;4(6):493-8. DOI: 10.1016/j.urpr.2016.11.003.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Garayev A., Aytac O., Tavukcu H.H. et al. Effect of autologous fibrin glue on lymphatic drainage and lymphocele formation in extended bilateral pelvic lymphadenectomy in robot-assisted radical prostatectomy. J Endourol 2019;33(9):761-6. DOI: 10.1089/end.2018.0853.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Waldert M., Remzi M., Klatte T. et al. FloSeal reduces the incidence of lymphoceles after lymphadenectomies in laparoscopic and robot-assisted extraperitoneal radical prostatectomy. J Endourol 2011;25(6):969-73. DOI: 10.1089/end.2010.0635.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Kowalewski K.F., Hendrie J.D., Nickel F. et al. Prophylactic abdominal or retroperitoneal drain placement in major uro-oncological surgery: a systematic review and meta-analysis of comparative studies on radical prostatectomy, cystectomy and partial nephrectomy. World J Urol 2020;38(8):1905-17. DOI: 10.1007/s00345-019-02978-2.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Zhong W., Roberts M.J., Saad J. et al. A systematic review and meta-analysis of pelvic drain insertion after robot-assisted radical prostatectomy. J Endourol 2020;34(4):401-8. DOI: 10.1089/end.2019.0554.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Chenam A., Yuh B., Zhumkhawala A. et al. Prospective randomised non-inferiority trial of pelvic drain placement vs no pelvic drain placement after robot-assisted radical prostatectomy. BJU Int 2018;121(3):357-64. DOI: 10.1111/bju.14010.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Person B., Vivas D.A., Ruiz D. et al. Comparison of four energy-based vascular sealing and cutting instruments: a porcine model. Surg Endosc 2008;22(2):534-8. DOI: 10.1007/s00464-007-9619-8.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Newcomb W.L., Hope W.W., Schmelzer T.M. et al. Comparison of blood vessel sealing among new electrosurgical and ultrasonic devices. Surg Endosc 2009;23(1):90-6. DOI: 10.1007/s00464-008-9932-x.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Box G.N., Lee H.J., Abraham J.B. et al. Comparative study of in vivo lymphatic sealing capability of the porcine thoracic duct using laparoscopic dissection devices. J Urol 2009;181(1):387-91. DOI: 10.1016/j.juro.2008.08.122.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Harold K.L., Pollinger H., Matthews B.D. et al. Comparison of ultrasonic energy, bipolar thermal energy, and vascular clips for the hemostasis of small-, medium-, and large-sized arteries. Surg Endosc 2003;17(8):1228-30. DOI: 10.1007/s00464-002-8833-7.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Grande P., Di Pierro G.B., Mordasini L. et al. Prospective randomized trial comparing titanium clips to bipolar coagulation in sealing lymphatic vessels during pelvic lymph node dissection at the time of robot-assisted radical prostatectomy. Eur Urol 2017;71(2):155-8. DOI: 10.1016/j.eururo.2016.08.006.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>White I., Mills J.K., Diggs B. et al. Sentinel lymph node biopsy for melanoma: comparison of lymphocele rates by surgical technique. Am Surg 2013;79(4):388-92.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Tsuda N., Ushijima K., Kawano K. et al. Prevention of lymphocele development in gynecologic cancers by the electrothermal bipolar vessel sealing device. J Gynecol Oncol 2014;25(3):229-35. DOI: 10.3802/jgo.2014.25.3.229.</mixed-citation></ref><ref id="B24"><label>24.</label><citation-alternatives><mixed-citation xml:lang="en">Nyushko K.M., Krasheninnikov A.A., Temirgereev M.Z. et al. Method of prevention of lymphorrhea and lymphocyst in patients with prostate cancer after surgical treatment. Invention RU 2674976 C2, 13.12.2018. Application No. 2018111102 dated 28.03.2018. (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Нюшко К.М., Крашенинников А.А., Темиргереев М.З. и др. Способ профилактики лимфореи и лимфокист у больных раком предстательной железы после хирургического лечения. Патент на изобретение RU 2674976 C2, 13.12.2018. Заявка № 2018111102 от 28.03.2018.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
